Rintaro Nozu

Sapporo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Successful treatment with zanubrutinib for Bing-Neel syndrome progressing on ibrutinib: a case report and literature review.

Successful treatment with zanubrutinib for Bing-Neel syndrome progressing on ibrutinib: a case report and literature review.

Journal: Leukemia & lymphoma

Published: April 08, 2026

Development of progressive multifocal leukoencephalopathy after cord blood transplantation in a patient with refractory angioimmunoblastic T-cell lymphoma.

Development of progressive multifocal leukoencephalopathy after cord blood transplantation in a patient with refractory angioimmunoblastic T-cell lymphoma.

Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

Published: January 06, 2024

Donor Lymphocyte Infusion for Relapsed Acute Leukemia or Myelodysplastic Syndrome after Hematopoietic Stem Cell Transplantation: A Single-Institute Retrospective Analysis.

Donor Lymphocyte Infusion for Relapsed Acute Leukemia or Myelodysplastic Syndrome after Hematopoietic Stem Cell Transplantation: A Single-Institute Retrospective Analysis.

Journal: Internal medicine (Tokyo, Japan)

Published: May 24, 2023

A case of Hodgkin lymphoma-type Richter syndrome presenting as small-intestinal perforation.

A case of Hodgkin lymphoma-type Richter syndrome presenting as small-intestinal perforation.

Journal: International journal of hematology

Published: May 13, 2023

EMA401, an angiotensin II type 2 receptor antagonist blocks visceral hypersensitivity and colonic hyperpermeability in rat model of irritable bowel syndrome.

EMA401, an angiotensin II type 2 receptor antagonist blocks visceral hypersensitivity and colonic hyperpermeability in rat model of irritable bowel syndrome.

Journal: Journal of pharmacological sciences

Published: February 22, 2021

Losartan improves visceral sensation and gut barrier in a rat model of irritable bowel syndrome.

Losartan improves visceral sensation and gut barrier in a rat model of irritable bowel syndrome.

Journal: Neurogastroenterology and motility

Published: October 16, 2019

Butyrate inhibits visceral allodynia and colonic hyperpermeability in rat models of irritable bowel syndrome.

Butyrate inhibits visceral allodynia and colonic hyperpermeability in rat models of irritable bowel syndrome.

Journal: Scientific reports

Published: September 05, 2019

Dehydroepiandrosterone sulfate improves visceral sensation and gut barrier in a rat model of irritable bowel syndrome.

Dehydroepiandrosterone sulfate improves visceral sensation and gut barrier in a rat model of irritable bowel syndrome.

Journal: European journal of pharmacology

Published: December 20, 2018

Altered colonic sensory and barrier functions by CRF: roles of TLR4 and IL-1.

Altered colonic sensory and barrier functions by CRF: roles of TLR4 and IL-1.

Journal: The Journal of endocrinology

Published: August 17, 2018

Pioglitazone improves visceral sensation and colonic permeability in a rat model of irritable bowel syndrome.

Pioglitazone improves visceral sensation and colonic permeability in a rat model of irritable bowel syndrome.

Journal: Journal of pharmacological sciences

Published: August 14, 2018

Metformin inhibits visceral allodynia and increased gut permeability induced by stress in rats.

Metformin inhibits visceral allodynia and increased gut permeability induced by stress in rats.

Journal: Journal of gastroenterology and hepatology

Published: April 25, 2018

Lovastatin inhibits visceral allodynia and increased colonic permeability induced by lipopolysaccharide or repeated water avoidance stress in rats.

Lovastatin inhibits visceral allodynia and increased colonic permeability induced by lipopolysaccharide or repeated water avoidance stress in rats.

Journal: European journal of pharmacology

Published: September 26, 2017

Showing 1-12 of 16

Last Updated: 09/26/2026